SAN DIEGO, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Erik Holmlin, PhD, Bionano’s president and chief executive officer, will present at the H.C.

Explore the precision of Vericheck ddPCR compared to AUC in analyzing AAV capsid content to enhance gene therapy safety and efficacy.

Bionano Genomics ( ($BNGO) ) has released its Q2 earnings. Here is a breakdown of the information Bionano Genomics presented to its investors.

SAN DIEGO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the second quarter ended June 30, 2025.

Q2 2025 Management View CEO Robert Erik Holmlin described the second quarter of 2025 as “solid,” emphasizing the positive effects of the strategic shift made in September 2024, which prioritized ...

Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the second quarter ended June 30, 2025. "We continued to execute on our new strategy ...